The Playground

Falling (Sports) Stars: Reports of Myocarditis in Athletes following the COVID-19 Vaccine

Falling (Sports) Stars: Reports of Myocarditis in Athletes following the COVID-19 Vaccine

Recently well-known cardiologist Dr. Peter McCullough sat down to discuss the effects of COVID-19 vaccines on some of the world’s top athletes on an

trialsitenews.com

Recently well-known cardiologist Dr. Peter McCullough sat down to discuss the effects of COVID-19 vaccines on some of the world’s top athletes on an episode of what is known as “The Dr. Ardis Show.” TrialSite previously reported on Dr. Peter McCullough when he suggested that health authorities reconsider administering vaccines to individuals under the age of 30, summarizing his perspectives on the pandemic. The interview covered the recent observations of healthy professional athletes collapsing and dying on the field, and how this occurrence can be connected to the COVID-19 vaccines.

This most recent show occurred on the Dr. Ardis Show hosted by a controversial chiropractor named Dr. Bryan Ardis. He has been an outspoken critic of the COVID-19 vaccine. TrialSite, an unbiased and objective media platform offers a multiplicity of views on medical research topics—both critical and aligned with popular narratives.

Linking COVID-19 Vaccines to Myocarditis

Throughout history, instances of sudden deaths in athletes due to cardiac arrest have always occurred. This has mostly been traced back to a genetic condition known as hypertrophic cardiomyopathy where the heart muscle becomes unusually thick and struggles to pump blood. Most collegiate and professional athletes in the United States are now screened for this condition before competing. Screening, coupled with advances in sports rehydration, has lessened the likelihood of professional athletes collapsing due to heart problems.

Since the roll-out of the COVID-19 vaccines, there has been an influx of athletes suffering heath failure and sudden death on the field. This phenomenon is becoming so common that Dr. Peter McCullough suspects the COVID-19 vaccines may be to blame. “80% of athletes at the collegiate and professional level have received the vaccine,” Dr. McCullough stated on “The Dr. Ardis Show” episode. Although athletes and sports teams are not required to disclose their vaccination status, this statistic was taken from athletes at the 2020 Tokyo Olympics as well as through discussions with major sports teams.

According to Dr. McCullough, officials from the Center for Disease Control (CDC) disclosed the relationship between myocarditis and the Pfizer and Moderna vaccines in June 2021 and updated their statement in November 2021. “It was clear to the officials that the vaccines were causing heart inflammation, but they said the cases were both mild and rare,” said Dr. McCullough. It would appear from real-world reports, however, that the incidents of myocarditis after vaccination are neither mild nor rare. In fact, the risk of myocarditis in younger people and athletes following vaccination was previously reported by TrialSite.

Severity of Myocarditis Cases

Myocarditis is an inflammation of the heart muscles that can reduce the heart’s ability to pump blood. Myocarditis is usually caused by a viral infection, but it may also result from a negative reaction to a drug. Symptoms of myocarditis include chest pain, fatigue, rapid or irregular heartbeats, and shortness of breath. Studies in both adults and children have found that males are more susceptible than females, accounting for 77-80% of clinical myocarditis cases.

Dr. McCullough stated that myocarditis occurred in 4 people per million before the COVID-19 pandemic, which equates to approximately 800 cases per year in the United States. Since COVID-19 vaccines began being administered, there have been upwards of 11 000 cases of myocarditis in the U.S. This contradicts the statement by the CDC that the occurrence of myocarditis is rare.

The medical community is continuing to report on cases of myocarditis in their vaccinated patients. A study published in the New England Journal of Medicine by Verma, Lavine and Lin (2021) reported two severe cases: the first in a 45-year old woman who recovered with treatment, and the second in a 42-year-old man who died three days later.

Papers from South Korea have also investigated myocarditis in vaccinated individuals. Choi et al. (2021) reported the death of a 22-year-old man 7 hours after his first dose of the Pfizer vaccine. Histopathology of the heart showed massive inflammatory infiltration, predominantly neutrophils. A paper by Kim et al (2021) also investigated the sudden occurrence of myocarditis in a healthy 24-year-old male shortly after receiving the COVID-19 vaccine. A further report by Lim et al (2021) details a case of near-fatal fulminant myocarditis in a previously healthy 38-year-old woman seven days after vaccination.

These reports further contradict the CDC statement that the cases of myocarditis are mild, as these published cases are severe and often lethal. “Reports are coming in hot and heavy of myocarditis being fatal,” says Dr. McCullough.

Another study that explored the occurrence of myocarditis in adolescents was conducted by Foltran et al. (2021) and is currently in pre-print as of December 2021. This study analyzed 4942 reports following mRNA COVID-19 vaccines in adolescents aged 12 to 17 years old. The study found 242 cases of pericarditis and/or myocarditis, 85% of which were reported in males. Most reports were serious (95%), with 79% requiring hospitalization. There was one fatality.

A paper written by Avolio et al. (currently in pre-print) suggests that the spike proteins generated from the COVID-19 vaccines disrupt cardiac pericytes, also known as support cells, in the heart. The nature of the spike protein is possibly injurious to the heart and can cause myocarditis in otherwise healthy individuals. “The spike protein is the last thing you want in the human body,” said Dr. McCullough. There exist huge complications between the mRNA vaccines, spike proteins generated by the vaccines, the heart muscle, and myocarditis.

Are the Vaccines to Blame?

As many athletes and sports teams do not disclose their vaccination status, it is possible that athletes are collapsing because of undiagnosed conditions. Since hypertrophic cardiomyopathy is screened out before an athlete becomes professional, however, it seems unlikely.

In the episode, Dr. McCullough said the standard management of myocarditis is to diagnose it with an EKG and a physical. Once myocarditis is detected, it can be successfully treated with prescribed drugs and no physical activity for months. The problem arises when athletes do not want to miss practice or important sporting events and so do not get tested. Without the testing, cardiac death is more likely to occur – the same type of death that we have been seeing in the headlines.

“Grossly unsafe” vaccines

Dr. McCullough emphasized in the interview that he is not against vaccines, and even got an influenza vaccine not too long ago. McCullough has been critical of this particular vaccine but is not a general “anti-vaxxer.” Driving his concern in this whole pandemic is the autocratic nature of how decisions are made. For example, only a few government-selected officials telling the world what is happening with the pandemic. TrialSite has reported on the positive elements of the vaccine—for example, the data indicate the positive impact on reduction in severe injury and death due to COVID-19. But reports of adverse events are not fully investigated. And a culture of fear and intimidation over healthcare professionals ensures. A uniform message, led by government officials continuously republishes the message that the vaccines are safe and effective – but TrialSite continues to find evidence of waning efficacy of the vaccines – and there is no external review to verify the efficacy claims on Americans. Moreover, while the safety incidence by no means impacts everyone they most certainly impact some of the vaccinated—enough to have raised alarms with previous vaccines for example. “The vaccines…are grossly unsafe with all the vaccine-induced deaths and acknowledged vaccine injury syndromes,” concluded Dr. McCullough. TrialSite will continue to monitor the reported adverse effects of the COVID-19 vaccines, including the increase in myocarditis in healthy individuals, as well as the differences in natural immunity and efficacy of vaccines

Better life by pharma?

The impact of drugs on gut microbes is greater than we thought

From cardiometabolic drugs to antibiotics – the medication we take can affect the human gut microbiome

Date:

December 8, 2021

Source:

European Molecular Biology Laboratory

Summary:

We are one of the most medicated generations of humans to live on our planet. Cardiometabolic diseases like type 2 diabetes, obesity, and coronary artery disease continue to increase in prevalence and together constitute the highest cause of mortality worldwide. Affected people often have to take multiple daily medications for months or even years. Researchers from the Bork group at EMBL Heidelberg, working together with a European consortium involving more than twenty European institutes, have now shown that many commonly used drugs have powerful effects on our gut microbes. These include drugs used to treat cardiometabolic disorders and antibiotics. The results were published in the journal Nature.

The impact of drugs on gut microbes is greater than we thought: From cardiometabolic drugs to antibiotics – the medication we take can affect the human gut microbiome

We are one of the most medicated generations of humans to live on our planet. Cardiometabolic diseases like type 2 diabetes, obesity, and coronary artery…

www.sciencedaily.com

We are one of the most medicated generations of humans to live on our planet. Cardiometabolic diseases like type 2 diabetes, obesity, and coronary artery disease continue to increase in prevalence and together constitute the highest cause of mortality worldwide. Affected people often have to take multiple daily medications for months or even years.

Researchers from the Bork group at EMBL Heidelberg, working together with a European consortium involving more than twenty European institutes, have now shown that many commonly used drugs have powerful effects on our gut microbes. These include drugs used to treat cardiometabolic disorders and antibiotics. The results were published in the journal Nature.

The gut microbiome consists of billions of microorganisms essential to the body's normal functioning.

"We analysed the effects of 28 different drugs and several drug combinations," explained Peer Bork, Director of Scientific Activities at EMBL Heidelberg, "Many drugs negatively impact the composition and state of the gut bacteria, but others, including aspirin, can have a positive influence on the gut microbiome. We found that drugs can have a more pronounced effect on the host microbiome than disease, diet, and smoking combined."

While the negative and lasting impact of antibiotics on gut bacteria is already well-known, this study showed that such effects likely accumulate over time. "We found that the gut microbiome of patients taking multiple courses of antibiotics over five years became less healthy. That included signs indicating antimicrobial resistance," said co-first author of the study Sofia Forslund, a former postdoctoral fellow in the Bork group and now group leader at the Max Delbrück Center for Molecular Medicine (MDC), Berlin.

"We wanted to disentangle the effect that diseases have on host microbiomes from the effect of medications, particularly in patients taking more than one drug at the same time," said co-first author Maria Zimmermann-Kogadeeva, group leader and former postdoc at EMBL Heidelberg. "Being part of the MetaCardis consortium enabled us to use multi-omics data from more than 2000 patients with cardiometabolic diseases," she added. The large cohort also allowed the researchers to establish that the dosage of drugs prescribed also has a significant effect on the level of impact on the microbiome.

"We know that the microbiome can reflect the status of a patient's health and provide a range of biomarkers to assess the severity of diseases. What is often overlooked, however, is that the medication used to treat a disease also affects the state of the microbiome," added Rima Chakaroun, one of the lead authors of the study and a clinician scientist at the University of Leipzig Medical Center. Dr Chakaroun is currently a postdoctoral fellow at the Wallenberg Laboratory, University of Gothenburg.

By developing a statistical approach that accounts for the effects of multiple confounding factors, the researchers could tease out the effects of drugs and disease separately. "We now have a robust methodological framework that makes it possible to get rid of many of the standard errors," said Professor Bork. "That allowed us to show that medication can mask the signatures of disease and conceal potential biomarkers or therapeutic targets."

The researchers are hopeful that these results can provide knowledge that could potentially help in drug repurposing as well as in planning individualised treatment and prevention strategies.

The study combined the insight, knowledge and approaches of experts in six countries. "It was very motivating to work with an interdisciplinary team of clinicians, bioinformaticians, and computational systems biologists to advance our understanding of molecular interactions in cardiometabolic disease," said Dr Zimmermann-Kogadeeva

sitting in the sun cuts risk of MS? By 50%? I wonder what that association has to do with it?

New study sheds light on link between sun exposure and MS

Kids, teens, young adults who spent 30 minutes outside daily cut risk of MS in half

MINNEAPOLIS - A new study suggests that children, teens and young adults who spend more time outdoors during the summer months and live in areas of the country that expose them to greater amounts of ultraviolet light have a lower risk of developing multiple sclerosis (MS) as children. While rare, MS can develop in children, although most people start to get symptoms of the disease between the ages of 20 and 50. The research is published in the December 8, 2021, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study also found that those who had more sun exposure during their first year of life also had lower odds of MS.

“Providing guidance on the best amounts of sunlight exposure to get while weighing the benefits against the risks is challenging,” said study author Emmanuelle Waubant, MD, PhD, of the University of California San Francisco and a Fellow of the American Academy of Neurology. “We found that spending between one and two hours outdoors daily provided the most benefit, but spending as little as 30 minutes outside daily may cut risk of MS roughly in half.”

The study involved 332 people with MS who had the disease for an average of seven months. They were matched with 534 people of similar age and sex who did not have MS. Participants ranged in age from three to 22.

Sun exposure was measured as time spent outdoors, use of sun protection like a hat, clothing and sunscreen, plus the amount of ultraviolet light exposure based on where participants lived at birth and at the time of the study. The children or their parents or guardians answered a questionnaire about how much time they spent outdoors daily at various ages and in the past year.

In the summer before the study, 19% of the participants with MS said they spent less than 30 minutes outdoors, compared to 6% of those who did not have MS. And 18% of the participants with MS spent one to two hours outdoors, compared to 25% of those without MS.

After adjusting for smoke exposure, sex and other factors that could affect MS risk, researchers found that people who spent an average of 30 minutes to an hour outside daily in the summer before the study had a 52% lower chance of MS compared to those who spent an average of less than 30 minutes outdoors daily. Those who averaged even more time outside daily, between one and two hours, had an 81% lower chance of MS than those who spent an average of less than 30 minutes outdoors daily.

“It’s important to note that too much sun exposure without protection also has risks, and our study found that spending two hours or more outside daily did not further reduce the risk of MS compared to one to two hours,” Waubant said.

Greater time spent outdoors in the first year of life was associated with lower odds of MS. Researchers found location also mattered. More intense sunlight where a participant lives was associated with lower odds of MS. For example, researchers estimate that someone living in Florida is 21% less likely to have MS compared to someone living in New York.

The study does not prove that sun exposure prevents MS, but it shows an association.

A limitation of the study is that children and their parents or guardians had to recall sun exposure and use of sun protection from years earlier and that recall may not be accurate.

The study was supported by the National Institutes of Health and the National MS Society.

Learn more about multiple sclerosis at BrainandLife.org, home of the American Academy of Neurology’s free patient and caregiver magazine focused on the intersection of neurologic disease and brain health. Follow Brain & Life® on Facebook, Twitter and Instagram.

When posting to social media channels about this research, we encourage you to use the hashtags #Neurology and #AANscience.

The American Academy of Neurology is the world’s largest association of neurologists and neuroscience professionals, with over 36,000 members. The AAN is dedicated to promoting the highest quality patient-centered neurologic care. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as Alzheimer’s disease, stroke, migraine, multiple sclerosis, concussion, Parkinson’s disease and epilepsy.

For more information about the American Academy of Neurology, visit AAN.com or find us on Facebook, Twitter, Instagram, LinkedIn and YouTube

Quote from Fm1

Dr. McCullough stated that myocarditis occurred in 4 people per million before the COVID-19 pandemic, which equates to approximately 800 cases per year in the United States. Since COVID-19 vaccines began being administered, there have been upwards of 11 000 cases of myocarditis in the U.S.

Be aware that our clown soon will post an other mafia study that explains the contrary...

Quote from Fm1

A new study suggests that children, teens and young adults who spend more time outdoors during the summer months and live in areas of the country that expose them to greater amounts of ultraviolet light have a lower risk of developing multiple sclerosis (MS) as children.

Wait for the clown explanation. Happiness protects....

Switzerland has a strong uptick in deaths. Lets guess who dies...80+ dies 300x more often than <50.

What will clowns say about risk reduction by gen therapy among age < 50... Even > 50% of 80+ deaths are double vaxx by the clown celebrated great working "vaccine"...

But what about age < 50? Soap slipping kills 100/year 3x CoV-19. Car accidents about 200/year. Smoking, heart attacks, etc .... even more.

I want a vaccine against "soap slipping ASAP"!!!!

Quote from Fm1

Dr. McCullough stated that myocarditis occurred in 4 people per million before the COVID-19 pandemic, which equates to approximately 800 cases per year in the United States. Since COVID-19 vaccines began being administered, there have been upwards of 11 000 cases of myocarditis in the U.S. This contradicts the statement by the CDC that the occurrence of myocarditis is rare.

WE know that myocarditis is a rare side effect of COVID vaccines, and a common side effect of COVID infection.

Since in many countries now the rate of COVID infection is quite high you would expect myocarditis from COVID to be the cause of any overall uptick? After all, we know COVID infection causes (serious) myocarditis, and at a rate higher than vaccination causes mild myocarditis. So this evidence is being misattributed here.

To show this was vaccines you would need to split myocarditis positives according to prior infection and vaccination status - and compare that with the overall population rates of prior infection and vaccination. I'd welcome a paper doing this.

THH

As said clowns never read papers. Myocarditis from CoV-19 is a different form than induced from the free floating Pfizer/Moderna spike protein induced one. The same you may get from any virus...

So the serious Myocarditis rate is now 30x increased with gene therapy. And of course the Pfizer spike one is never mild as it leaves behind dead tissues aka scarves.

This is the price you may pay for being a Guinea big in clown medicine...

The poor Indians that all lost their worms still wait for a next wave. Or may be they just have fun as we had 2 years ago....

Japan that always widely used Ivermectin has 1/10 of the average vaccine terror nations death count.

But people start to cry for worm. They miss them...

Quote from Fm1

sitting in the sun cuts risk of MS? By 50%? I wonder what that association has to do with it?

It is not clear. From the details in the paper:

time outside correlated with lower MS:

Time spent outdoors: Greater time spent outdoors during the present/most recent summer on
weekends was associated with significantly lower odds of MS, with evidence of a dosedependent response (Table 4, model 1; Supplementary eTable 2, model 2). Compared to
spending <30 minutes outdoors daily, spending 30 minutes-1 hour had a clinically relevant
50% lower odds of MS, though this observation did not reach statistical significance

Sun protection: Use of sun protection in the most recent summer was not significantly
associated with the odds of MS (Supplementary eTable 3, model 3). Adding both time spent
outdoors and use of sun protection as predictors in the same model did not improve model fit
compared to the model with only time spent outdoors (Table 4, model 2).

Ambient UVR dose: Greater ambient UVR dose in the most recent summer (in a model not
including time outdoors and sun protection behaviours) was associated with lower odds of
MS but this observation did not reach statistical significance (AOR=0.83, 95%CI 0.68-1.00,
p=0.05) (Supplementary eTable 3, model 4)

Higher serum 25(OH)D concentration (post-diagnostic) was associated with greater odds of
MS (AOR=1.06 per ng/mL, 95%CI 1.04-1.08, p<0.001) (Supplementary eTable 5, model 3).
When time spent outdoors, use of sun protection, ambient summer UVR dose, and serum
25(OH)D concentration were included as predictors in the same model, higher serum
25(OH)D concentration remained associated with greater odds of MS (AOR=1.07 per
ng/mL, 95%CI 1.05-1.09, p<0.001) (Supplementary eTable 5, model 3). We tested for
interaction effects between time outdoors, use of sun protection, ambient UVR levels, and
serum 25(OH)D but did not detect any significant interactions.

From this I'd say it is a muddy picture: most likely the main effect is more exercise (which tends to make everything better) causing lower MS

In addition higher serum 25(OH)D correlated with higher MS. But this is an association - as always it is very difficult to get definite info about Vit D.

So I'd say there are weak indications here that:

Vit D might increase MS (very weak - since correlation is particularly not causation in this case)

exercise might decrease MS

They are only weak indications.

THH

McMaster University Working on Inhalable COVID-19 Vaccine ‘Game Changers’ As Phase 1 Study Starts in 2022

McMaster University Working on Inhalable COVID-19 Vaccine ‘Game Changers’ As Phase 1 Study Starts in 2022

New inhalable investigational vaccines for COVID-19 have been authorized for clinical trials starting in 2022. Led by a group of McMaster University

trialsitenews.com

New inhalable investigational vaccines for COVID-19 have been authorized for clinical trials starting in 2022. Led by a group of McMaster University scientists in Canada, two novel inhalable COVID-19 vaccines, to be administered as boosters, would be offered to healthy people who previously received the two-dose regimen of approved or authorized COVID-19 vaccines. Easily accessible, authorized, inhalable, safe, and effective COVID-19 vaccines would be game-changers for Canada and beyond.

TrialSite provides a brief overview for the community.

Why nasal spray as an approach for COVID-19 vaccines?

They can be far more accessible, easy to use, and would halt the infection at the body’s entry point—that is, the novel coronavirus pathogen infecting cells in the nasal passages prior to moving up into the lungs as well as other organs.

How is this different from the mRNA vaccines?

Among other things, these nasal vaccines address more than just the spike protein—which is the focus of the mRNA vaccines (Pfizer-BioNTech and Moderna).

What is the McMaster vaccine?

They have developed a vaccine that contains three of the proteins, according to Fiona Smaill, Professor of Pathology and Molecular Medicine at McMaster University. She declared the novel part of the vaccine includes both the development and administration aspects. Instead of giving by intramuscular injection, rather they use inhalants using a small jet nebulizer. If authorized, this inhaled vaccine would be far more accessible than the current first-generation vaccines.

Matt Miller, Associate Professor at the Michael G. DeGroote Institute for Infectious Disease Research, reports, “These inhaled vaccines represent an improvement on the current generation COVID vaccines because instead of targeting only the spike protein which is the part of the virus that mutates most rapidly to hide from our immune system it also encodes two other pieces of the virus that the virus has a very hard time changing.”

This inhaled version of the vaccine does something special, reports Miller: “it puts the immune system in the lungs on a high alert—called trained innate immunity which is a way our immune system can become more prepared to deal with any infection in the future.”

How long has the inhaled version been a concept?

For decades. In fact, this vaccine draws on two decades of research and development on a tuberculosis vaccine led by Zhou Xing, co-principal investigator, and professor in the Department of Medicine and McMaster Immunology Research Centre.

Professor Xing went on the record, “Our vaccine strategy differs from all of the current first-generation COVID-19 vaccines in the route of delivery. Ours gets delivered into the lung via inhaled aerosol to induce respiratory mucosal immunity, known to provide the best protection against respiratory pathogens.”

What’s next?

Researchers will examine how the immune response develops in the lungs and blood after vaccination and will monitor for possible side effects.

What type of vaccine?

Researchers are comparing two strains of weakened adenovirus as platforms for the vaccines. In their natural form, adenoviruses cause respiratory infections such as the common cold, and in rare cases can cause a lung infection such as pneumonia. In their weakened form they do not spread disease but can be customized to serve as vehicles, or vectors, to trigger targeted immune responses.

“McMaster has a very long and illustrious history in the study of adenoviruses. This human trial builds on that pioneering work, and in addition to addressing an issue of tremendous public health importance, will also advance our fundamental understanding of how to use these viruses most effectively as vaccine vectors,” says Matthew Miller, an associate professor with McMaster’s Michael G. DeGroote Institute for Infectious Disease Research and co-principal investigator.

Where were the vaccines produced?

These vaccines were developed at McMaster’s Robert E. Fitzhenry Vector Laboratory, one of the few facilities in Canada with the capacity to develop and produce viral vector vaccines for clinical trials.

The effort has been led by Brian Lichty, associate professor of the Department of Medicine. The overall effort is part of McMaster’s Global Nexus for Pandemics and Biological Threats.

What’s next for a clinical trial?

At least 30 healthy volunteers will take part in the study, which is funded by the Canadian Institutes for Health Research. If Phase 1 is successful, the team has manufactured sufficient vaccine doses to move forward with much larger clinical trials, which could potentially lead to broader use, the researchers say.

Lead Research/Investigator

Michael G. DeGroote Institute for Infectious Disease Research and co-principal investigator.

Call to Action: TrialSite will follow the forthcoming phase 1 clinical trial

Researchers to begin human trials for promising new inhaled COVID-19 vaccines designed to combat variants of concern

Vaccines developed at McMaster target the lungs first.

brighterworld.mcmaster.ca

Moderna data shows mRNA isn’t a quick fix for the flu vaccine

Early data isn’t blowing anyone away

Moderna data shows mRNA isn’t a quick fix for the flu vaccine

Production speed might still matter.

www.theverge.com

Wow a possible lab leak?

PLAYING WITH FIRE Terrifying Covid LAB LEAK feared to have infected dozens in Taiwan in ‘chilling echo of Wuhan’

Covid LAB LEAK feared to have infected 85 in Taiwan in ‘echo of Wuhan’

A FEMALE lab worker in Taiwan is feared to have infected dozens of people with Covid in a terrifying leak, officials said. The researcher in capital Taipei who…

www.the-sun.com

A FEMALE lab worker in Taiwan is feared to have infected dozens of people with Covid in a terrifying leak, officials said.

The researcher in capital Taipei who tested positive for the coronavirus may have caught it during experiments in the laboratory, local media reports

Quote from Fm1

Wow a possible lab leak?

PLAYING WITH FIRE Terrifying Covid LAB LEAK feared to have infected dozens in Taiwan in ‘chilling echo of Wuhan’

https://www.the-sun.com/news/4…ovid-lab-leak-taiwan/amp/

A FEMALE lab worker in Taiwan is feared to have infected dozens of people with Covid in a terrifying leak, officials said.

The researcher in capital Taipei who tested positive for the coronavirus may have caught it during experiments in the laboratory, local media reports

Display More

A mass spreader event - no lab needed - many do worse going into a night club without a mask.

Largegathering without social disatncing or masks are obviously not as terrifying as labs. Technophobia?

Quote from THHuxleynew

A mass spreader event - no lab needed - many do worse going into a night club without a mask.

Largegathering without social disatncing or masks are obviously not as terrifying as labs. Technophobia?

So what are you saying , that the media created a story to justify the increase in cases? But you yourself have said the media doesn't create fear. Technophobia, that cracks me up. So you don't believe this was a lab leak?

Prominent Spatiotemporal Waves of COVID-19 Incidence in the United States: Implications for Causality, Forecasting, and Control

Abstract

Better understanding of the spatiotemporal structure of the COVID-19 epidemic in the USA may help inform more effective prevention and control strategies. By analyzing daily COVID-19 case data in the United States, Mexico and Canada, we found four continental-scale epidemic wave patterns, including travelling waves, that spanned multiple state and even international boundaries. These major epidemic patterns co-varied strongly with continental-scale seasonal temperature change patterns. Geo-contiguous states shared similar timing and amplitude of epidemic wave patterns irrespective of similarities or differences in state government political party affiliations. These analyses provide evidence that seasonal factors, probably weather changes, have exerted major effects on local COVID-19 incidence rates. Seasonal wave patterns observed during the first year of the epidemic may become repeated in the subsequent years.

One Sentence Summary The COVID-19 epidemic in the United States has consisted of four continental-scale spatiotemporal waves of case incidence that have spanned multiple states and even international boundaries.

Since the first case of COVID-19 was reported in Wuhan, China in December 2019, an ongoing global pandemic of COVID-19 has led to 180 million cases and 3.9 million deaths (1). In the United States, the national epidemic incidence has waxed and waned four times, with varying intensity in different regions of the country (2). Possible causes for changing case rates include changes in social distancing, mask wearing, and other epidemic control polices; emergence of viral variants; changes in the weather; introduction of vaccines; and other factors.

Spatiotemporal analysis of COVID-19 can provide improved understanding of patterns and drivers of the COVID-19 epidemic in a given geographic region. By comparing epidemic patterns across the country, it is possible to identify clusters of locations that share similar patterns. For example, Kang et al showed the spread of COVID-19 from the Hubei province where the first outbreak occurred in China to neighboring provinces (3). Another study in Brazil traced the trajectories of the geographic center of the epidemic over time to understand the spread of COVID-19 in the country (4). For the US, Zhu D et al used a network modeling to examine the spatial shifting patterns of COVID-19 from February to August in 2020 (5). As more than a full year of data are available now, the spatiotemporal patterns of COVID-19 can reveal the association between geographical properties and the spatiotemporal patterns of COVID-19. Furthermore, spatiotemporal pattern can be better understood, if the pattern is compared with the neighboring countries such as Canada and Mexico in case of the USA.

Quote from THHuxleynew

A mass spreader event - no lab needed - many do worse going into a night club without a mask.

Largegathering without social disatncing or masks are obviously not as terrifying as labs. Technophobia?

Did you read the article. The lab tech is suspected of being infected by a mouse bit, with a mouse infected by the lab. Transmission by animal bite deserves more than your techno crap

Here the latest UK Vaccine report: https://assets.publishing.serv…ance_report_-_week_49.pdf

The only change is the slight decrease in cases of the vaccinated age 70+ that still are higher than unvaxx if we count in the >50% recovered. So the booster effect is about 20% so far.

The signal for ultra low birth weight - premature birth is strong for vaccinated woman and is clearly outside and variation. Of course the absolute numbers for added cases are not given - would be to shocking may be.

The cheating for sero Ig-G positives cases goes on as we know its 30% to low at least. The figures they publish are just in line with the actual case numbers... But for gamma the silent ratio was 3 already...

Of course they tell people age 70+ are blood donors and also the infected ones ...In all countries blood donors are a small set < 5% of the population mostly age 20..60...so this cheating it outrageous.

But clowns will have to wait for the official discussion in a FM/R/J/B journal...

India still waits for CoV-19 wave. Except Kerala/Mizoram.....

In all western vaccine terror states we clearly see that case numbers have no relation with vaccination. Only Ivermectin treatment & prevention states like India or most central Africa states do great. Also Japan has a very low death rate.

Booster are only a marginal help to stop the pandemic as UK shows and also Israel. But the death numbers among 60+ are reduced.

Why did we allow the FM/R/B mafia to kill millions of people just for drug dealing profit?

Why do 80% of the people believe that they need an experimental gene therapy? This pseudo vaccination only prolongates the pandemic as it harms natural immunity.

In reality only a few people need such a treatment. Especially among age 80+ that here currently die at a rate of about > 500x compared to age < 50.

CDC Report: 80% of U.S. Omicron Cases in Fully Vaccinated

CDC Report: 80% of U.S. Omicron Cases in Fully Vaccinated

Note that views expressed in this opinion article are the writer’s personal views and not necessarily those of TrialSite. Dr. Ron Brown – Opinion

trialsitenews.com

December 11, 2021

Centers for Disease Control and Prevention (CDC) released a surveillance report on Friday, December 10, 2021, describing 43 U.S. Omicron cases in 22 states during the first week of December, 2021: Omicron — U.S., December 1–8, 2021. No Omicron deaths and one hospitalization were reported. Younger people between the ages of 18–39 accounted for the majority of Omicron cases (58%), while people under 18 and over 65 each accounted for only 9% of cases. Female cases outnumbered male cases (58% and 40%, respectively). Fully vaccinated people accounted for 47% of cases and fully vaccinated people with a booster accounted for an additional 33% of cases, totalling 80% fully vaccinated Omicron cases compared to 19% unvaccinated cases.

The surveillance report found that 93% of Omicron cases were symptomatic, and 16% of cases experienced breathing difficulties and shortness of breath. People who had travelled internationally during the 14 days prior to the onset of symptoms totaled 33% of cases. It’s still too early to tell how Omicron will affect the population over time, but based on the CDC’s initial surveillance report showing a high percentage of cases in the fully vaccinated, the days of a “pandemic of the unvaccinated” may be coming to an end: COVID-19: stigmatising the unvaccinated is not justified – The Lancet.

COVID-19: stigmatising the unvaccinated is not justified

DEFINE_ME

Interesting email in my UK inbox today...

Hello

Just wanted to ask you all to consider sending a quick email to your MPs about domestic covid passports that are once again back on the table as part of the government's "Plan B".

Domestic covid passports have already been rejected back in July by the Public Administration and Constitutional Affairs Committee who said in their report that there is "no justification for them in the science and none in logic".

Although Boris has said passports are coming, they are not yet law and there will be a vote in parliament this Tuesday so it's really important that we talk to our MPs before then.

Big Brother Watch has done an excellent job of articulating the problems these passes would introduce into our society. Their website https://bigbrotherwatch.org.uk…epassports/#email-your-mp provides an easy to copy and paste message that you can use to your MP and an easy to use "Find my MP" link.

And if you'd like to hear the head of big brother watch talk about this. There is a short clip from her interview on TalkRadio here https://twitter.com/talkRADIO/status/1468862109790396417

Thanks so much for taking the time to read this - I appreciate that this isn't a fun thing to think about.

Is Authoritarianism Knocking on Europe’s Door?

Is Authoritarianism Knocking on Europe’s Door?

A group of Members of European Parliament (MEPs) held a press conference to discuss what they believe is imminent authoritarianism emerging in Europe due

trialsitenews.com

A group of Members of European Parliament (MEPs) held a press conference to discuss what they believe is imminent authoritarianism emerging in Europe due to responses by European governments and the European Commission now openly discussing a continent-wide vaccine mandate. During a Dec. 1 press conference, European Commission (EC) president Ursula von der Layden declared that the prospect of mandatory vaccination continent-wide must happen now. In response, led by Romanian MEP Christian Terhes, a group of MEPs from multiple countries declared the legitimacy of the current governments in Europe is at stake over this issue of forced mandates. The current European digital green certificate and booster program, according to the EC president, has been a great success. The handful of MEPs warned all authoritarianism now knocks on Europe’s door in the video.

Will Europe remain a free democratic society or turn into a heavily controlled, medically guided authoritarianism led by the COVID-19 responses based on a number of imposed mandates, backed by censorship via the social networks, mainstream media, and of course compliant politicians? That’s the stark, ominous situation as presented by these particular MEPs.

Prompting the MEPS to publicly discuss was a press conference at the start of the month when a journalist asked Ursula von der Layden about the digital green certificate and booster program; she responded it was a huge success.

According to the EC president, vaccines are valid for 9 months while the vaccine works for 6 months thus the people of Europe are given a “grace period” of 3 months to exercise their basic rights. Asked about the prospect of mandatory vaccines Europe-wide, the president responded she was absolutely supportive and that a discussion should start now. Declaring 1/3 of Europe isn’t vaccinated, she believes all people should be vaccinated except for very young people (babies) and some rare cases where health contraindications apply.

Thus, the anger, furor, and proactive resolve by these few MEPs resisting what they believe to be a movement to force a vaccine regimen Europe-wide—and the urgent need to resist such a reality.

On the other hand, governments in Europe seek to seamlessly integrate the patchwork of different mandatory pandemic rules now in place. They seek an efficient and effective means to go back to a normalcy that perhaps, and unfortunately, may not exist anymore.